TherapeuticsMD (NASDAQ:TXMD) Coverage Initiated by Analysts at StockNews.com

Equities research analysts at StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD) in a research report issued to clients and investors on Friday. The brokerage set a “hold” rating on the stock.

TherapeuticsMD Stock Performance

Shares of TherapeuticsMD stock opened at $1.46 on Friday. TherapeuticsMD has a 52-week low of $0.70 and a 52-week high of $2.44. The stock’s 50-day simple moving average is $1.01 and its 200 day simple moving average is $1.14.

TherapeuticsMD Company Profile

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.